These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25416209)

  • 1. [Local treatment of purulent-necrotic complications of diabetic foot syndrome].
    Feoktistov V; Shakeyev K; Akhmetova S; Zhanassova M; Berkut M
    Georgian Med News; 2014 Oct; (235):7-11. PubMed ID: 25416209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological justification of the effectiveness of ultrasonic cavitation with 0.2].
    Chekmareva IA; Blatun LA; Paskhalova YS; Mitish VA; Paklina OV; Terekhova RP; Sepeda P; Magomedova SD; Ushakov AA; Sokov SL
    Khirurgiia (Mosk); 2019; (7):63-70. PubMed ID: 31355817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of antral on the immunological and hemodynamic indices in the treatment of purulent-necrotic complications of diabetes mellitus].
    Gelunenko AM
    Klin Khir; 2000 Oct; (10):13-5. PubMed ID: 11247419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial therapy of purulent necrotic foot lesions in patients with diabetes mellitus].
    Podpriatov SIe; Larionov HM; Simonova ZIe; Tovkun VK
    Klin Khir; 2001 Aug; (8):42-7. PubMed ID: 11794111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vast purulent necrotic lesions in patients with diabetes mellitus].
    Liul'ko IB; Kosul'nikov SO; Tarnopolskiĭ SA
    Klin Khir; 2001 Aug; (8):28-30. PubMed ID: 11794104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of prostaglandin E1 and systemic antibacterial therapy application in patients with diabetes mellitus and purulent-necrotic lesions of the foot].
    Podpriatov SIe; Hrabovyĭ OM; Salata VV; Zaĭtsev SV; Simonova ZIe; Korbut SM; Shyshova SIa; Rohacheva VP
    Klin Khir; 2010; (11-12):76-8. PubMed ID: 21268804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of purulent necrotic complications in patients with diabetic foot syndrome].
    Datsenko BM; Belov SG; Girka EI
    Klin Khir; 2001 Aug; (8):10-2. PubMed ID: 11794095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of alprostan in combination with "Bioptron-II" rays and iruxol-miramistin in the treatment of the diabetic foot complicated by atherosclerosis].
    Tomashuk IP; Tomashuk II
    Klin Khir; 2001 Aug; (8):49-51. PubMed ID: 11794113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NO-therapy in the treatment of purulent and necrotic lesions of lower extremities in diabetic patients].
    Shulutko AM; Antropova NV; Kriuger IuA
    Khirurgiia (Mosk); 2004; (12):43-6. PubMed ID: 15699957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of vascular therapy in complex of treatment of purulent necrotic foot ulcers in patients with diabetes mellitus].
    Podpriatov SIe; Lisovets' VV; Huch AO; Tovkun VK; Slobodeniuk IM; Hupalo IuM
    Klin Khir; 2001 Feb; (2):27-9. PubMed ID: 11482020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPARATIVE CHARACTERISTICS OF TREATMENT RESULTS USING THE OFFLOADING MEANS IN PATIENTS WITH PURULENT-NECROTIC COMPLICATIONS OF DIABETIC FOOT SYNDROME.
    Shevchenko RS; Shevchenko SI; Pryimenko DS; Tsyganenko OS; Feskov VM
    Wiad Lek; 2021; 74(8):1891-1893. PubMed ID: 34537738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of purulent and necrotic lesions of the lower extremities in patients with diabetes mellitus].
    Ohonovsky? VK; Podil?hak MD; Matskiv AS; Kravets SL; Tsemekhin BD
    Klin Khir (1962); 1993; (9-10):37-40. PubMed ID: 8158919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration.
    Weck M; Rietzsch H; Lawall H; Pichlmeier U; Bramlage P; Schellong S
    Thromb Haemost; 2008 Sep; 100(3):475-82. PubMed ID: 18766265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ways of improvement in surgical treatment of purulent-necrotic complications in the diabetic foot syndrome].
    Antoniuk SM; Sviridov NV; Golovnia PF; Andrienko IB; Akhrameev VB; Lomako AI
    Klin Khir; 2002; (11-12):91-3. PubMed ID: 12549315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Causes of unsatisfactory outcome in patients with diabetes mellitus complicated by necrotic inflammation of the foot].
    Fedorenko VP
    Klin Khir; 1999; (3):16-9. PubMed ID: 10370287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of purulent complications of diabetes mellitus].
    Verkhuletskiĭ IE; Medvedenko AF; Voronoĭ AL
    Klin Khir; 1998; (7):17-8. PubMed ID: 9989077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Compartment syndrome in patients with diabetic foot syndrome complicated by purulent necrotic lesions].
    Mikhnevych OE; Horielov SV; Bezliuda NP; Sapa SA
    Klin Khir; 2001 Aug; (8):33-5. PubMed ID: 11794107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of the glicemia level in elderly and senile patients with diabetes mellitus, operated for purulent-necrotic foot lesion].
    Ivashchenko VV; Kolkin Iag; Koval'chuk VS; Ivashchenko AV
    Klin Khir; 2005 Aug; (8):51-4. PubMed ID: 16445063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of diabetic foot infections.
    Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
    Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prolonged intraarterial medicinal therapy of the destructive forms of diabetic foot syndrome].
    Antoniuk SM; Sviridov MV; Andrienko IB; Karabak SG; Barkalov SV
    Klin Khir; 2005 Sep; (9):26-8. PubMed ID: 16445040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.